Agios Pharmaceuticals (AGIO) Free Cash Flow Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 31.42% |
| 10 | Agios Pharmaceuticals | 2.21 Bn | 1.47 Bn | 19.43 Mn | -7.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.79% |
| Dec 31, 2025 | -16.03% |
| Sep 30, 2025 | -4.50% |
| Jun 30, 2025 | -2.97% |
| Mar 31, 2025 | -3.74% |
| Dec 31, 2024 | -15.01% |
| Sep 30, 2024 | 20.11% |
| Jun 30, 2024 | -2.20% |
| Mar 31, 2024 | -3.06% |
| Dec 31, 2023 | -108.00% |
| Sep 30, 2023 | 18.79% |
| Jun 30, 2023 | -31.76% |
| Mar 31, 2023 | 4.81% |
| Dec 31, 2022 | 12.99% |
| Sep 30, 2022 | 4.59% |
| Jun 30, 2022 | 7.21% |
| Mar 31, 2022 | 1.53% |
| Dec 31, 2021 | -5.81% |
| Sep 30, 2021 | -37.91% |
| Jun 30, 2021 | -0.35% |